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carboxylated osteocalcin increases 
pancreatic insulin production and 
secretion is not clear. Second, if bone 
resorption is so critical to the posttrans-
lational modification of osteocalcin and 
therefore insulin secretion, are individu-
als on antiresorptive therapy for osteo-
porosis more likely to be insulin resis-
tant and glucose intolerant? In a small 
observational study, Kaji et al. (2009) 
report that fasting glucose levels are 
higher in women treated for 2 years with 
alendronate, the most commonly used 
treatment for osteoporosis. However, fat 
mass does not differ in these patients, 
and the statistical relationship between 
bone density and fasting glucose dis-
appears when corrected for changes in 
lean mass. In addition, previous human 
investigations clearly demonstrate that 
an oral glucose load that increases 
insulin secretion suppresses markers of 
bone resorption by 50% (Clowes et al., 
2003). Most importantly, and yet much 
more difficult to address, is whether the 
relationship between bone and energy 
metabolism provides an evolutionary 
advantage and, if so, where skeletal 
control fits into the complex hierarchy 
of acute and chronic regulation of insu-
lin secretion during physiologic states. 
Notwithstanding these unanswered 
questions, these two studies provide a 
strong framework for understanding the 
emerging role of the skeleton in meta-
bolic homeostasis.
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2807–2817.Life is all about capturing energy and 
putting it to use seeking more energy, 
avoiding being someone else’s energy, 
building and repairing parts, and mak-
ing more life. In eukaryotic cells, the 
mitochondria are the processing plants 
where the major forms of energy cur-
rency, such as ATP, are generated by 
catabolism of nutrients and consump-
tion of oxygen. Much of mitochon-
drial research of the last 50 years has 
focused on how this flow and con-
version of energy is controlled. But 
it is only in the last few years that we 
have realized that this process is an 
important node in the complex signal 
transduction machinery that extends 
throughout the cell and connects it to 
the external environment. In a sense, 
we are seeking the links between infor-
mation and energy in the cell. Now, a 
paper in this issue provides one such 
link: Cardenas et al. (2010) report that 
calcium constitutively released from 
the endoplasmic reticulum (ER) by 
the inositol 1,4,5-triphosphate recep-
tor (IP3R) is taken up by mitochondria 
where it is required for efficient oxygen 
consumption and ATP production.
When eukaryotic cells are starved of 
nutrients, they engage the process of 
autophagy to catabolize themselves to 
survive, and this is generally triggered by 
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the inhibition of mTOR, which 
otherwise inhibits autophagy 
by phosphorylation of two 
of the initiating factors 
(Hosokawa et al., 2009). A link 
between ER calcium efflux 
and autophagy was discov-
ered when it was noted that 
pharmacologic inhibition of 
the IP3R induces autophagy 
under conditions of nutri-
ent sufficiency (Vincencio 
et al., 2009). Cardenas and 
colleagues confirm this and 
extend the findings to DT40 
cells (a chicken lymphoma 
line) in which all three forms 
of IP3R have been knocked 
out (Sugawara et al., 1997). 
Other transformed cells, as 
well as primary hepatocytes 
and smooth muscle cells, 
similarly undergo autophagy 
upon IP3R inhibition, and this 
depends on the activation of 
adeonsine monophosphate-
activated protein kinase 
(AMPK), a sensor of energy 
insufficiency (Hardie, 2007). 
Surprisingly, this appears 
to be independent of mTOR 
function, at least in the 
transformed cells, a point to 
which we will return. These 
cells continue to consume 
glucose but nevertheless 
engage autophagy, which 
is required for their survival. 
Thus the energy require-
ments of the cell were not being met due 
to a defect in mitochondrial oxidative 
phosphorylation. Although introduction 
of wild-type IP3R into the knockout cells 
restores energy production and inhib-
its autophagy, a mutant IP3R incapable 
of inducing calcium efflux from the ER 
does not, and thus calcium is identified 
as the relevant signal. Indeed, elegant 
imaging studies confirm that in smooth 
muscle cells, constitutive low-level cal-
cium efflux occurs in an IP3R-dependent 
manner.
ER and mitochondria are closely asso-
ciated in cells, and calcium released from 
the ER is efficiently taken up into the mito-
chondrial matrix, where it enhances the 
activities of several key enzymes, includ-
ing pyruvate dehydrogenase (PDH), two 
enzymes in the tricarboxylic acid (TCA) 
cycle (ketoglutarate dehydrogenase and 
isocitrate dehydrogenase), and the F0F1 
ATPase (Balaban, 2009). PDH is inhib-
ited by phosphorylation, and calcium 
activates one of the PDH phosphatases 
(PDPs) that remove the inhibitory phos-
phate groups from PDH and thereby acti-
vate it. Cardenas et al. show that the reg-
ulation of PDH is a key step; inhibitors of 
the PDH kinase (either a pharmacologic 
inhibitor or pyruvate itself) restore oxygen 
consumption and energy generation. This 
is probably not a general effect, as hepa-
tocytes express a specific PDP isoform 
that is calcium independent (Sugden and 
Holmes, 2003), and thus the other cal-
cium targets mentioned above may pre-
dominate in these cells.
The picture that emerges, 
then, is that constitutive 
signaling from cell surface 
growth factor receptors gen-
erates IP3, which triggers cal-
cium efflux from the ER, and 
this promotes the conversion 
of pyruvate into acetyl-coA in 
the mitochondria, TCA cycle 
activity, and production of 
ATP by the electron trans-
port chain. When the IP3R 
is not induced, energy lev-
els drop, AMPK is activated, 
and autophagy is engaged to 
preserve energy and cell sur-
vival.
However, there is a funda-
mental problem with this view. 
Transformed cells, including 
DT40, utilize glucose predomi-
nantly to generate nucleotides, 
amino acids, and lipids. The 
latter requires that citrate is 
shuttled from the matrix to 
the cytosol, disrupting the 
TCA cycle. To compensate, 
glutamine is taken up and 
converted to glutamate and 
then to α-ketoglutarate in the 
matrix to restore the cycle and 
thereby maintain energy gen-
eration (DeBerardinis et al., 
2007). Indeed, glutamine con-
sumption in both the wild-type 
and IP3R-deficient DT40 cells 
is highly active (and, if any-
thing, the latter show higher 
levels) (Cardenas et al., 2010). 
However, this process is incompatible 
with autophagy: catabolism of cytosolic 
components (such as proteins and lipids) 
that are generated in the cell represents 
a net loss in energy. Yet, the DT40 cells 
lacking IP3R proliferate without high levels 
of apoptosis (Sugawara et al., 1997). And 
indeed, mTOR, which promotes protein 
production and other cell-cycle require-
ments, is active in these cells (Cardenas 
et al., 2010). The scheme, with some of 
the possible roles for autophagy (dis-
cussed below), is shown in Figure 1.
One possibility is that the autophagy 
observed when IP3R is blocked or 
absent is not for the purpose of energy 
generation, per se. Autophagy also 
functions to remove damaged organ-
elles, and it is conceivable that cal-
figure 1. eR-to-mitochondria transfer of calcium Ions
Proposed role for calcium ions in the control of metabolic flux and autophagy 
in transformed cells. Steady-state growth factor receptor signaling generates 
inositol 1,4,5-triphosphate (IP3), which binds to the IP3 receptor (IP3) to trig-
ger calcium efflux. Calcium (shown in red) is taken up into the mitochondrial 
matrix, where it promotes several activities (shown in red): the conversion 
of pyruvate to acetyl-CoA (AcCoA), the tricarboxylic acid (TCA) cycle, and 
the generation of ATP by the electron transport chain. In transformed cells, 
much of the pyruvate (from glycolysis) is converted to lipid via export of cit-
rate, and the TCA cycle is sustained by glutamine uptake and conversion to 
α-ketoglutarate (αKG). When calcium efflux is limited, ATP production de-
clines, and AMPK is activated. This in turn activates autophagy, which can 
generate energy via catabolism, providing the raw materials for generation of 
AcCoA (for example), and sustaining energetics. An alternative possibility is 
that the induced autophagy is involved in removal of damaged endoplasmic 
reticulum (ER-phagy). It is unlikely that the synthetic and autophagic path-
ways coexist at the same time in dividing cells, as this would represent a 
severe net energy loss, likely to impede cell proliferation.Cell 142, July 23, 2010 ©2010 Elsevier Inc. 201
cium imbalance in the ER triggers 
autophagic removal of ER that has 
become dysfunctional. Vincencio et 
al. (2009) suggest that disruption of an 
interaction between IP3R and Beclin-1, 
a protein involved in autophagy target-
ing and initiation, is responsible for 
the induction of autophagy when IP3R 
is inhibited. However, Cardenas et al. 
find that a mutant IP3R that is capable 
of binding Beclin-1 but deficient in 
calcium efflux function fails to block 
autophagy in the knockout cells. This 
does not preclude the possibility that 
the observed autophagy is, in effect, 
restricted to “ER-phagy” but does not 
explain why AMPK activation is neces-
sary for the observed autophagy.
Alternatively, it may be that the 
autophagy observed is indeed for 
energy production, but that it is cyclic. 
DT40 cells deficient in IP3R display a 
marked increase in cells in S phase 
(Sugawara et al., 1997). This effect has 
not been commented upon, and it is 
not clear that this is observed for other 
cells in which IP3R activity is inhib-
ited. Might it be that in such cells, S 
phase is “stalled” due to low energy, 
and autophagy is engaged at this 
point to provide enough raw materials 
to bypass the block at PDH, provid-
ing acetyl-coA via β-oxidation of lip-
ids? Although increased autophagy is 
observed, it is only seen in about 15% 
of cells. It would be interesting to know 
if these cells are in a delayed S phase. 
But if so, can we be sure that the path-
way from AMPK to autophagy is truly 
independent of mTOR? It may be that 
the majority of the cells (that are not 
“stalled”) may represent those with 
functional mTOR, as this is a known 
target of AMPK (Laplante and Sabatini, 
2009)? Although intriguing, at this point 
it may be too early to say whether there 
is an AMPK-dependent, mTOR-inde-
pendent pathway for autophagy. But 
then again maybe not, as a recent sur-
vey of the human autophagy machin-
ery has indeed found an interaction of 
AMPK with the serine/threonine kinase 
ULK1, which acts at the earliest steps 
of autophagy (Behrends et al., 2010).
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